We are live on ! Find out more
PI

Putnam Investments Portfolio holdings

AUM $75.7B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+402.82%
AUM
$42.8B
AUM Growth
+$187M
Cap. Flow
-$989M
Cap. Flow %
-2.31%
Top 10 Hldgs %
22.38%
Holding
1,437
New
198
Increased
383
Reduced
472
Closed
341

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$281M
2
DXC icon
DXC Technology
DXC
+$280M
3
UNH icon
UnitedHealth
UNH
+$182M
4
NOC icon
Northrop Grumman
NOC
+$159M
5
CMCSA icon
Comcast
CMCSA
+$130M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$270M
2
CSC
Computer Sciences
CSC
+$221M
3
WFC icon
Wells Fargo
WFC
+$217M
4
MS icon
Morgan Stanley
MS
+$174M
5
LLY icon
Eli Lilly
LLY
+$131M

Sector Composition

Rank Sector Weight
1 Healthcare 17.79%
2 Financials 14.47%
3 Communication Services 13.13%
4 Technology 12.86%
5 Industrials 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGF.A
1251
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-19,400
Closed -$515K
BECN
1252
DELISTED
Beacon Roofing Supply, Inc.
BECN
-27,773
Closed -$1.36M
ENZ
1253
DELISTED
Enzo Biochem, Inc.
ENZ
-583,350
Closed -$4.88M
SAVE
1254
DELISTED
Spirit Airlines, Inc.
SAVE
-125,269
Closed -$6.65M
PRMW
1255
DELISTED
Primo Water Corporation
PRMW
-290,048
Closed -$3.58M
VGR
1256
DELISTED
Vector Group Ltd.
VGR
-131,871
Closed -$1.68M
EGRX
1257
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-78,412
Closed -$6.5M
PRFT
1258
DELISTED
Perficient Inc
PRFT
-61,927
Closed -$1.07M
BIG
1259
DELISTED
Big Lots, Inc.
BIG
-8,186
Closed -$399K
AEL
1260
DELISTED
American Equity Investment Life Holding Company
AEL
-115,916
Closed -$2.74M
PGTI
1261
DELISTED
PGT, Inc.
PGTI
-388,312
Closed -$4.17M
MIXT
1262
DELISTED
MIX TELEMATICS LIMITED
MIXT
-174,300
Closed -$1.1M
CHS
1263
DELISTED
Chicos FAS, Inc.
CHS
-87,647
Closed -$1.24M
RPT
1264
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-38,099
Closed -$534K
AVTA
1265
DELISTED
Avantax, Inc. Common Stock
AVTA
-137,948
Closed -$2.39M
CCF
1266
DELISTED
Chase Corporation
CCF
-11,677
Closed -$1.11M
NEWR
1267
DELISTED
New Relic, Inc.
NEWR
-35,793
Closed -$1.33M
ZYNE
1268
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-27,970
Closed -$562K
SYNH
1269
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-31,551
Closed -$1.45M
NUVA
1270
DELISTED
NuVasive, Inc.
NUVA
-5,315
Closed -$397K
PDCE
1271
DELISTED
PDC Energy, Inc.
PDCE
-67,600
Closed -$4.21M
AIMC
1272
DELISTED
Altra Industrial Motion Corp
AIMC
-17,792
Closed -$693K
SIOX
1273
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-4,107
Closed -$491K
HZN
1274
DELISTED
Horizon Global Corporation
HZN
-198,700
Closed -$2.76M
LCI
1275
DELISTED
Lannett Company, Inc.
LCI
-9,882
Closed -$884K

Similar funds

Putnam Investments's Q2 2017 Portfolio in Review

As of Q2 2017, Putnam Investments held 1,437 positions worth $42.8B, up 0.44% from $42.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Putnam Investments's Q2 2017 filing shows 198 new, 383 increased, 472 reduced and 341 closed positions. Its largest new stake was DXC Technology: 4,221,734 shares worth $280M. The largest sale was CR Bard Inc., an estimated $270M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Communication Services.

  • Putnam Investments's largest Q2 2017 buy was DXC Technology: 4,221,734 shares worth $280M.
  • Putnam Investments added most to Becton Dickinson in Q2 2017, an estimated $281M increase.
  • Putnam Investments's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $270M.
  • Putnam Investments fully exited Computer Sciences in Q2 2017, selling an estimated $221M.
  • Putnam Investments's ten largest holdings make up 22% of its $42.8B portfolio in Q2 2017.
  • Putnam Investments opened 198 new positions and closed 341 in Q2 2017.
  • Putnam Investments's portfolio value rose 0.44% quarter-over-quarter to $42.8B.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.